accesso® Names Mike Evenson as Chief Commercial Officer
Proven SaaS Ticketing Leader to Guide Global Commercial Strategy and Drive Market Expansion
With more than 20 years of leadership at the intersection of technology, ticketing, live events, and customer engagement, Evenson brings deep expertise in scaling high-performing teams and advancing customer-centric innovation. At AudienceView, he held a series of diverse and progressive executive roles, including VP of Marketing and Product Management, VP of Strategy, and Chief Marketing Officer, where he unified brand, product, and go-to-market strategy to drive growth and transformation across the business.
"As we enter our next phase of growth, Mike's proven ability to identify new markets, build lasting partnerships, and optimize commercial operations makes him an outstanding addition to our executive team," said
About accesso Technology Group plc
accesso is the leading global provider of patented and award-winning technology solutions that redefine the guest experience, drive increased revenue, streamline operations, and support data-driven business decisions for leisure and entertainment operators. Currently serving over 1,100 venues worldwide, accesso invests heavily in research and development to provide venues with technology that empowers unforgettable guest experiences. Staffed by a team of attractions, cultural venue, and ski industry veterans, accesso partners with venues to maximize guest engagement and revenue through intuitive ticketing, point-of-sale, virtual queuing, distribution, and experience management technologies.
accesso is a public company, listed on AIM: a market operated by the London Stock Exchange. Learn more at accesso.com or follow accesso on X (Twitter), LinkedIn and Facebook.
View original content to download multimedia:https://www.prnewswire.com/news-releases/accesso-names-mike-evenson-as-chief-commercial-officer-302548572.html
SOURCE accesso Technology Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AlgoLaser Launches DIY KIT MK3: Start, Just That Simple--A Smarter Way to Laser Engrave
- Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026
- Astral & Root Announces ETHERIC, A Transparent Neurowellness Supplement Built For High Pressure Professionals
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share